Laboratorio de Dermatologia e Imunodeficiencias (LIM-56), Departamento de Dermatologia e Institute de Medicina Tropical, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo 01246-903, Brazil.
Laboratorio de Dermatologia e Imunodeficiencias (LIM-56), Departamento de Dermatologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo 01246-903, Brazil.
World J Gastroenterol. 2021 Nov 28;27(44):7734-7738. doi: 10.3748/wjg.v27.i44.7734.
The recent manuscript reviewed investigations involving liver damage in coronavirus disease 2019 (COVID-19) patients, and COVID-19 in patients with previous chronic hepatological diseases, such as patients with liver graft. The literature presents several conflicting results concerning the anti-SARS-CoV-2 response in patients with solid organ transplants, in liver transplant recipients. Therefore, we would like to humbly state a few points for consideration involving liver transplant recipients and COVID-19, such as the time since transplantation, comorbidities, and immunosuppressive regimens.
这篇最近的手稿回顾了涉及 2019 年冠状病毒病（COVID-19）患者肝脏损伤的研究，以及先前患有慢性肝病（如肝移植患者）的 COVID-19 患者。文献中关于实体器官移植患者、肝移植受者中抗 SARS-CoV-2 反应的结果存在一些相互矛盾之处。因此，我们谨就肝移植受者和 COVID-19 涉及的几个问题提出几点看法，如移植时间、合并症和免疫抑制方案。
